Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
SAWAI GROUP HOLDINGS Co., Ltd.
ISIN JP3323040000
|WKN A2QQY4
Market cap (in EUR)
1,516 m
Country
Japan
Sector
Healthcare
Dividend yield
2.25%
Overview
Description
SAWAI GROUP HOLDINGS Co., Ltd. engages in medical and healthcare-related businesses. It deals with the manufacture and sale of pharmaceuticals and medical equipment as well as various activities incidental to or related to these businesses. It operates through the Japan and United States geographical segments. The company was founded on April 1, 2021 and is headquartered in Osaka, Japan.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Japan
Financials
Key metrics
| Market capitalisation, EUR | 1,516 m |
| EPS, EUR | -0.06 |
| P/B ratio | 1.6 |
| P/E ratio | 204.0 |
| Dividend yield | 2.25% |
Income statement (2024)
| Revenue, EUR | 1,156 m |
| Net income, EUR | 13 m |
| Profit margin | 1.15% |
What ETF is SAWAI GROUP HOLDINGS Co., Ltd. in?
There are 23 ETFs which contain SAWAI GROUP HOLDINGS Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of SAWAI GROUP HOLDINGS Co., Ltd. is the iShares MSCI Japan Small Cap UCITS ETF (Dist).
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.